CanSino Biologics’ Ad5-nCoV the First COVID-19 Vaccine to Phase II Clinical Trials
China’s CanSino Biologics recently disclosed that the company was advancing its SARS-CoV-2 vaccine to a Phase II clinical trial making […]
China’s COVID-19 Vaccine Called Ad5-nCoV Moves into Phase II Clinical Trial, 500 Volunteers Sought
CanSino Biologics is recruiting 500 volunteers for Phase II clinical trial investigating a vaccine targeting the COVID-19 virus. Touted as a […]
Pakistan Authorizes AZD1222 (AstraZeneca) for Emergency Use While SinoPharm is Next; Ad5nCoV in Phase 3 Trial
Pakistan authorized the use of the AstraZeneca COVID-19 vaccine recently. Approved for emergency use, the vaccine originally developed at University of […]
Made in Saskatchewan: New Canadian Subunit Vaccine Targeting COVID-19 Heads to Clinical Trial at The Canadian Centre for Vaccinology
The University of Saskatchewan’s Vaccine and Infectious Disease Organization (VIDO) has developed a COVID-19 vaccine headed to human clinical trials […]
From Zero to $40 Billion Vaccine Marker Overnight: Welcome to the COVID-19 Vaccine Market
COVID-19 has become a big business, a really big business. Going from nothing to a $40 billion dollar market, at least […]
Will China’s “Vaccine Diplomacy” Provide a Sustained Geopolitical Advantage?
A prominent U.S. military commander, Admiral Craig Fuller recently suggested in a video conference involving members of the Defense Writers […]
China’s Sinopharm Claims Nearly 1M Volunteers Inoculated with Inactive COVID-19 Vaccine Candidate
Various reports point to the inoculation of nearly one million people with the COVID-19 vaccine developed by China National Pharmaceutical […]
Mexico Secures COVID-19 Vaccine Candidates from CanSino Biologics & Others Via COVAX
Mexico was active recently in the investigational vaccine market, securing two deals with two different companies for a total of […]
Pakistan Struggles to Recruit Volunteers for Phase 3 CanSino Biologics Vaccine Trial: Military Involved
Pakistan, the fifth most populous nation in the world, recently geared up to support a Phase 3 COVID-19 vaccine clinical […]
Moderna Third Quarter Investor Earning Call Summary as Company Gears Up for Regulatory Moves
Moderna just today gave its Third Quarter 2020 Conference Call based on its earnings report, while disclosing its preparation for […]
